Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity
GB Pier - International journal of medical microbiology, 2007 - Elsevier
Pseudomonas aeruginosa is one of the most important bacterial pathogens encountered by
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity
GB Pier - International journal of medical microbiology …, 2007 - pubmed.ncbi.nlm.nih.gov
Pseudomonas aeruginosa is one of the most important bacterial pathogens encountered by
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.
GB Pier - International Journal of Medical Microbiology: IJMM, 2007 - europepmc.org
Pseudomonas aeruginosa is one of the most important bacterial pathogens encountered by
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
[HTML][HTML] Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity
GB Pier - International journal of medical microbiology: IJMM, 2007 - ncbi.nlm.nih.gov
Pseudomonas aeruginosa is one of the most important bacterial pathogens encountered by
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
[引用][C] Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity
GB PIER - Int J Med Microbiol, 2007 - cir.nii.ac.jp
Pseudomonas aeruginosa lipopolysaccharide : a major virulence factor, initiator of
inflammation and target for effective immunity | CiNii Research CiNii 国立情報学研究所 学術 …
inflammation and target for effective immunity | CiNii Research CiNii 国立情報学研究所 学術 …
Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunity
GB Pier - International Journal of Medical Microbiology, 2007 - infona.pl
Pseudomonas aeruginosa is one of the most important bacterial pathogens encountered by
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunity
GB Pier - International Journal of Medical Microbiology, 2007 - Elsevier
Pseudomonas aeruginosa is one of the most important bacterial pathogens encountered by
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
[引用][C] Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunity
G PIER - International Journal of Medical Microbiology, 2007 - cir.nii.ac.jp
Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation
and target for effective immunity | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
and target for effective immunity | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.
GB Pier - International Journal of Medical Microbiology: IJMM, 2007 - europepmc.org
Pseudomonas aeruginosa is one of the most important bacterial pathogens encountered by
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …
immunocompromised hosts and patients with cystic fibrosis (CF), and the lipopolysaccharide …